continuous erythropoiesis receptor activator

…used, and newer forms—such as continuous erythropoiesis receptor activator (CERA), which was developed for persons affected by kidney disease—challenged existing detection technologies. In 2008 CERA was detected for the first time among cyclists competing in the Tour de France. It was also found in three track-and-field athletes, two cyclists, and…